Appendix for Examples of Real Data Analysis & Computer Printouts
I. In Vitro Combinations
I-A: 2 Drugs Inhibition of Enzyme Systems
I-A-a: Mixed Constant & non-Constant Ration Design (All Data Points in the Table Used )
I-A-b: Constant Ration Design (Partial Data points Used)
I-A-c: Non-COnstant Ration Design (Partial Data points Used)
I-B: 2 & 3 Drugs Growth Inhibition in Cancer Cell Systems
II. In Vitro Combinations
II-A: 2 Insecticides against Housr Flies
II-B: 2 Drugs against Xenograft Tumors in Nude Mice (14 Slides)
II-C: 2 Drug Clinical Trials against HIV (2 Slides) Demonstration of An Efficient "Econo-Green" Bio-Research
I. In Vitro Combinations
Example I-A: Enzyme System: Two drugs
II. In Vitro Combinations
II-A: 2 Insecticides against Housr Flies
II-B: 2 Drugs against Xenograft Tumors in Nude Mice (14 Slides)
II-C: 2 Drug Clinical Trials against HIV (2 Slides) Demonstration of An Efficient "Econo-Green" Bio-Research
I. In Vitro Combinations
Example I-A: Enzyme System: Two drugs
• Appendix I, Example I-A Table of Crude Data: Enzyme System
Click to view Data Table for Example I-A
• CompuSyn Analysis OF I-A of Yonetani-Theorell Data from the Nobel Laboratory
Click to view CompuSyn Analysis for Example I-A
Example I-B: Cancer Cell System: 2- and/or 3- drugs
• Analysis of Combination Data for Taxol, Cisplatin and Topotecan
Click to view Experimental Design and Data Table for Example I-B
• Combinations I-B and Summary of Results. Cancer Cell System in Vitro.
CompuSyn Analysis for Example I-B
II. In Vivo Combinations
Example II-A: Insecticides for House Flies: 2 drugs
• Table for Original Data and Summary of Results.
Click to view Data Table and Result Summary
• Analysis for Combination Data II-A in the Table for Rotenone and Pyrethrins
Click to view CompuSyn Analysis for Examples II-A
Example II-B: Tumor Bearing Nude Mice: 2 drugs Combinations: A slide show for experimental data and computerized analysis
Example II-C: Anti-HIV Clinical Trials: 2 drugs Combinations: One slide summary indicating drug combination clinical trial errors in design and in data analysis.
